Suppr超能文献

小儿急性呼吸窘迫综合征患者部分液体通气的初步经验。

Initial experience with partial liquid ventilation in pediatric patients with the acute respiratory distress syndrome.

作者信息

Gauger P G, Pranikoff T, Schreiner R J, Moler F W, Hirschl R B

机构信息

Department of Surgery, University of Michigan Medical Center, Ann Arbor, USA.

出版信息

Crit Care Med. 1996 Jan;24(1):16-22. doi: 10.1097/00003246-199601000-00006.

Abstract

OBJECTIVE

Liquid ventilation with perfluorocarbon previously has not been reported in pediatric patients with respiratory failure beyond the neonatal period. We evaluated the technique of partial liquid ventilation in six pediatric patients with the acute respiratory distress syndrome of sufficient severity to require extracorporeal life support (ECLS).

DESIGN

This study was a noncontrolled, phase I/II experimental study with a single group pretest/posttest design.

SETTING

All studies were performed at a tertiary, pediatric referral hospital at the University of Michigan Medical School.

PATIENTS

Six pediatric patients, from 8 wks to 5 1/2 yrs of age, with severe respiratory failure requiring ECLS to support gas exchange.

INTERVENTIONS

After 2 to 9 days on ECLS, perfluorocarbon was administered into the trachea until the dependent zone of each lung was filled. The initial administered was 12.9 +/- 2.3 mL/kg (range 5 to 20). Gas ventilation of the perfluorocarbon-filled lungs (partial liquid ventilation) was then performed. The perfluorocarbon dose was repeated daily for a total of 3 to 7 days, with a cumulative dose of 45.2 +/- 6.1 mL/kg (range 30 to 72.5).

MEASUREMENTS AND MAIN RESULTS

All measurements of native gas exchange were made during brief periods of discontinuation of ECLS and include PaO2 and the alveolar-arterial oxygen gradient, P(A-a)O2. Static pulmonary compliance, corrected for weight, was also measured directly. The mean PaO2 increased from 39 +/- 6 to 92 +/- 29 torr (5.2 +/- 0.8 to 12.2 +/- 3.9 kPa) over the 96 hrs after the initial dose (p = .021 by repeated-measures analysis of variance). The average P(A-a)O2 decreased from 635 +/- 10 to 499 +/- 77 torr (84.7 +/- 1.3 to 66.5 +/- 10.3 kPa) over the same time period (p = .059), while the mean static pulmonary compliance (normalized for patient weight) increased from 0.12 +/- 0.02 to 0.28 +/- 0.08 mL/cm H2O/kg (p = .01). All six patients survived. Complications potentially associated with partial liquid ventilation were limited to pneumothoraces in two of six patients.

CONCLUSIONS

Perfluorocarbon may be safely administered into the lungs of pediatric patients with severe respiratory failure on ECLS and may be associated with improvement in gas exchange and pulmonary compliance.

摘要

目的

既往尚未有关于新生儿期以后的小儿呼吸衰竭患者进行全氟碳液体通气的报道。我们评估了6例患有急性呼吸窘迫综合征且病情严重到需要体外生命支持(ECLS)的小儿患者的部分液体通气技术。

设计

本研究为非对照的I/II期实验性研究,采用单组前后测设计。

地点

所有研究均在密歇根大学医学院的一家三级儿科转诊医院进行。

患者

6例年龄从8周至5.5岁的小儿患者,患有严重呼吸衰竭,需要ECLS来支持气体交换。

干预措施

在接受ECLS治疗2至9天后,将全氟碳注入气管,直至每侧肺的低垂部位充满。初始注入量为12.9±2.3 mL/kg(范围为5至20)。然后对充满全氟碳的肺进行气体通气(部分液体通气)。全氟碳剂量每天重复使用,共3至7天,累积剂量为45.2±6.1 mL/kg(范围为30至72.5)。

测量指标及主要结果

所有天然气体交换的测量均在短暂停止ECLS期间进行,包括动脉血氧分压(PaO₂)和肺泡 - 动脉氧分压差[P(A - a)O₂]。还直接测量了经体重校正的静态肺顺应性。在首次给药后的96小时内,平均PaO₂从39±6升至92±29托(5.2±0.8至12.2±3.9千帕)(重复测量方差分析,p = 0.021)。同期平均P(A - a)O₂从635±10降至499±77托(84.7±;1.3至66.5±10.3千帕)(p = 0.059),而平均静态肺顺应性(经患者体重标准化)从0.12±0.02升至0.28±0.08 mL/cm H₂O/kg(p = 0.01)。6例患者均存活。与部分液体通气可能相关的并发症仅限于6例患者中的2例发生气胸。

结论

对于接受ECLS治疗的严重呼吸衰竭小儿患者,可安全地将全氟碳注入肺内,且可能与气体交换和肺顺应性的改善有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验